Clinical Application of Aripiprazole Monohydrate Long-Acting Injectables for the Treatment of Schizophrenia: A Consensus Panel Report.

Correll CU, Achtyes ED, Sajatovic M, Saklad SR, Goldberg JF

Open source

DOI
10.4088/jcp.plunlai2424ah2
Published
2025 Aug 13
Container
The Journal of clinical psychiatry
Publisher
Not recorded
Open access
no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.4088/jcp.plunlai2424ah2,
  title = {Clinical Application of Aripiprazole Monohydrate Long-Acting Injectables for the Treatment of Schizophrenia: A Consensus Panel Report.},
  author = {Correll CU and Achtyes ED and Sajatovic M and Saklad SR and Goldberg JF},
  year = {2025},
  journal = {The Journal of clinical psychiatry},
  doi = {10.4088/jcp.plunlai2424ah2},
  url = {https://doi.org/10.4088/jcp.plunlai2424ah2}
}

RIS

TY  - JOUR
TI  - Clinical Application of Aripiprazole Monohydrate Long-Acting Injectables for the Treatment of Schizophrenia: A Consensus Panel Report.
AU  - Correll CU
AU  - Achtyes ED
AU  - Sajatovic M
AU  - Saklad SR
AU  - Goldberg JF
PY  - 2025
JO  - The Journal of clinical psychiatry
DO  - 10.4088/jcp.plunlai2424ah2
UR  - https://doi.org/10.4088/jcp.plunlai2424ah2
ER  - 

APA

CU, C., ED, A., M, S., SR, S., & JF, G. (2025). Clinical Application of Aripiprazole Monohydrate Long-Acting Injectables for the Treatment of Schizophrenia: A Consensus Panel Report.. The Journal of clinical psychiatry. https://doi.org/10.4088/jcp.plunlai2424ah2

Source records